Indian Journal of Urology Users online:1644  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others


Intravesical chemotherapy in non-muscle-invasive bladder cancer

Porten Sima P, Leapman Michael S, Greene Kirsten L

Year : 2015| Volume: 31| Issue : 4 | Page no: 297-303

   This article has been cited by
1 Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinoma
Clayton J. Bell, Kyle G. Potts, Mary M. Hitt, Desmond Pink, Jack A. Tuszynski, John D. Lewis
Cancer Letters. 2022; 526: 168
[Pubmed]  [Google Scholar] [DOI]
2 Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
Nikolay I. Nikolov, Vladislav R. Dunev, Angel A. Anatoliev, Nikolay H. Kolev, Martin B. Stoykov, Boyan S. Atanasov
Journal of Biomedical and Clinical Research. 2022; 15(1): 70
[Pubmed]  [Google Scholar] [DOI]
3 Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics
Jan P. Bogen, Julius Grzeschik, Joern Jakobsen, Alexandra Bähre, Björn Hock, Harald Kolmar
Frontiers in Oncology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
4 Current Systemic Treatment Options in Metastatic Urothelial Carcinoma after Progression on Checkpoint Inhibition Therapy—A Systemic Review Combined with Single-Group Meta-Analysis of Three Studies Testing Enfortumab Vedotin
Susanne Deininger, Peter Törzsök, David Oswald, Lukas Lusuardi
Cancers. 2021; 13(13): 3206
[Pubmed]  [Google Scholar] [DOI]
5 Efficacy of Bladder Intravesical Chemotherapy with Three Drugs for Preventing Non-Muscle-Invasive Bladder Cancer Recurrence
Jianglei Zhang, Miao Li, Ze Chen, Jun OuYang, Zhixin Ling, Le Sun
Journal of Healthcare Engineering. 2021; 2021: 1
[Pubmed]  [Google Scholar] [DOI]
6 Novel anticancer therapy in BCG unresponsive non-muscle-invasive bladder cancer
Mohamad Moussa, Athanasios G Papatsoris, Athanasios Dellis, Mohamed Abou Chakra, Wajih Saad
Expert Review of Anticancer Therapy. 2020; 20(11): 965
[Pubmed]  [Google Scholar] [DOI]
7 Synthesis, Characterization, and Biological Activity of Anthraquinone-Substituted Imidazolium Salts for the Treatment of Bladder Cancer
Michael L. Stromyer, David J. Weader, Uttam Satyal, Philip H. Abbosh, Wiley J. Youngs
Bladder Cancer. 2020; 6(4): 471
[Pubmed]  [Google Scholar] [DOI]
8 Squamous differentiation in pT1 bladder urothelial carcinoma predicts poor response for intravesical chemotherapy
Gang Li, Jieping Hu, Yuanjie Niu
Oncotarget. 2018; 9(1): 217
[Pubmed]  [Google Scholar] [DOI]
9 Intravesical electromotive drug administration for non-muscle invasive bladder cancer
Jae Hung Jung, Ahmet Gudeloglu, Halil Kiziloz, Gretchen M Kuntz, Alea Miller, Badrinath R Konety, Philipp Dahm
Cochrane Database of Systematic Reviews. 2017; 2017(9)
[Pubmed]  [Google Scholar] [DOI]


Read this article